Clinical Trial Update: Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWD [Phase 3]

View source ↗

Summary

A phase 3 clinical trial evaluating Wilate for efficacy and safety as prophylaxis in previously treated patients with von Willebrand disease has completed, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Willebrand Disease

Drugs mentioned

• Wilate (von Willebrand factor/factor VIII concentrate)

Snippet

Sponsor: Octapharma | Conditions: Von Willebrand Diseases | Phase 3 | Status: COMPLETED | Results posted: 2023-10-25